Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis
Cancer Letters · 2025-03 · 612 · 217486
DOI: 10.1016/j.canlet.2025.217486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-03. Verfasst von Xiaodong Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230000, Chin…. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Extracellular Vesicles, Tumor Escape, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The programmed cell death 1 (PD-1)/PD-1 ligand 1 (PD-L1) axis mediates immune evasion of tumor, and targeting this axis has achieved some clinical benefits. The regulation of PD-1 expression in immune cells has been well studied. However, whether any other potential source of immune cell-expressed PD-1 exists remains unknown. Here, we report that tumor cells express PD-1 and release PD-1 in the form of extracellular vesicles, which enters T cells and suppresses T cell function via PD-L1 in vitro. In vivo, tumor cell-derived extracellular vesicle PD-1 promotes tumor growth via disrupting peripheral T cell homeostasis, showing by decreased number of T cells and impaired function of CD8+ T cells in spleens, draining lymph nodes and tumor infiltrating lymphocytes, which is restored by PD-1-targeted antibodies. Our study provides a unique and novel perspective for immune evasion of tumor, and expands a source of PD-1 in immune cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230000, China; Chinese Academy of Sciences (CAS) Key Laboratory of Biomedical Diag…
- Affiliated Hospital of ZunYi Medical University, Zunyi 563000, China.
- Guizhou University, Guiyang, 550000, China.
- Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, 030001, China.
- Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Southeast University, Nanjing, 210096, China.
- Department of Oncology, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510530, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Yang, X., Huang, C., Liu, T., Zang, H., Gu, Y., Zhang, Y., Zhu, X., Zhang, C., Guo, F., Wu, S., Ding, A., Yin, R., Ye, Q., & Gao, S. (2025). Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis. Cancer Letters, 612, 217486. https://doi.org/10.1016/j.canlet.2025.217486
Vancouver
Wang X, Yang X, Huang C, Liu T, Zang H, Gu Y, et al. Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis. Cancer Letters. 2025;612:217486. doi:10.1016/j.canlet.2025.217486
BibTeX
@article{Wang2025,
author = {Wang, Xiaodong and Yang, Xiaohui and Huang, Chang and Liu, Tongfeng and Zang, Haojing and Gu, Yinmin and Zhang, Yibi and Zhu, Xiaofeng and Zhang, Chang and Guo, Fang and Wu, Songzhe and Ding, Ao and Yin, Rong and Ye, Qinong and Gao, Shan},
title = {Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis},
journal = {Cancer Letters},
year = {2025},
volume = {612},
pages = {217486},
doi = {10.1016/j.canlet.2025.217486}
}
EUVIMED